Humana (HUM) Gains from Investment Securities (2009 - 2025)

Humana's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at -$151.0 million for Q4 2025.

• In Q4 2025, Gains from Investment Securities rose 70.96% year-over-year to -$151.0 million; the TTM figure through Sep 2025 stood at -$369.0 million (up 4.65% YoY), while the FY2024 annual figure was $50.0 million, changed N/A from the prior year.
• Gains from Investment Securities was -$151.0 million for Q4 2025 at Humana, down from $122.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $675.0 million in Q2 2023 to a low of -$957.0 million in Q4 2023.
• Historically, Gains from Investment Securities has averaged $13.8 million across 5 years, with a median of $7.0 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities jumped 2876.92% in 2021, then sank 9487.5% in 2022.
• A 5-year view of Gains from Investment Securities shows it stood at $8.0 million in 2021, then tumbled by 9487.5% to -$751.0 million in 2022, then retreated by 27.43% to -$957.0 million in 2023, then surged by 45.66% to -$520.0 million in 2024, then surged by 70.96% to -$151.0 million in 2025.
• The last three Gains from Investment Securities figures came in at -$151.0 million (Q4 2025), $122.0 million (Q3 2025), and $41.0 million (Q2 2025), per Business Quant data.